Direct antiviral agents against hepatitis C virus: Beneficial or harmful?

被引：0
|
作者：
Murcia, Oscar [1 ]
Carnicer, Fernando [1 ]
Gomez-Escolar, Laura [2 ]
Miralles, Cayetano [3 ]
Pilar Grino, Maria [4 ]
Barquero Martin, Claudia [5 ]
Pascual, Sonia [1 ]
机构：
[1] Hosp Gen Univ Alicante, Dept Hepatol, Alicante, Spain
[2] Hosp Marina Baixa, Dept Hepatol, Villajoyosa, Spain
[3] Hosp Vinalopo, Dept Hepatol, Elche, Spain
[4] Hosp San Juan Alicante, Dept Hepatol, Alicante, Spain
[5] Hosp Gen Torrevieja, Dept Hepatol, Alicante, Spain
来源：
JOURNAL OF HEPATOLOGY | 2018年 / 68卷 / 04期
关键词：
INTERFERON-FREE THERAPY; EARLY TUMOR RECURRENCE; HEPATOCELLULAR-CARCINOMA; HCC; RISK;
D O I：
10.1016/j.jhep.2017.10.026
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：844 / 845
页数：2
相关论文
共 50 条
  • [1] Hepatocellular Carcinoma in the Era of Direct Antiviral Agents Against Hepatitis C Virus
    Aghemo A.
    Polverini D.
    Colombo M.
    Current Hepatology Reports, 2024, 23 (3) : 364 - 372
  • [2] Current Status of Direct Acting Antiviral Agents against Hepatitis C Virus Infection in Pakistan
    Khaliq, Saba
    Raza, Syed Mohsin
    MEDICINA-LITHUANIA, 2018, 54 (05):
  • [3] Hepatitis C Virus - Related Hepatocellular Carcinoma in the Era of Direct - Acting Antiviral Agents
    Liu, Xu
    Gao, Yanhang
    Niu, Junqi
    HEPATITIS MONTHLY, 2018, 18 (06)
  • [4] Hepatitis B virus in patients with chronic hepatitis C treated with direct antiviral agents
    Luisa Gutierrez-Garcia, Ma
    Luisa Manzano-Alonso, Ma
    Angel Ferrer-Rosique, Juan
    Munoz-Gomez, Raquel
    Alonso-Lopez, Sonia
    Fernandez-Alvarez, Inmaculada
    Fernandez-Rodriguez, Conrado M.
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2019, 111 (02) : 129 - 133
  • [5] Two Cases of Hepatocellular Carcinoma Occurring Immediately after Direct-acting Antiviral Agents against Hepatitis C Virus
    Nishijima, Norihiro
    Nasu, Akihiro
    Kimura, Toru
    Osaki, Yukio
    INTERNAL MEDICINE, 2019, 58 (02) : 225 - 231
  • [6] Effectiveness of direct acting antiviral agents for hepatitis C virus related recurrent hepatocellular carcinoma patients who had multiple courses of recurrence
    Ohki, Takamasa
    Sato, Koki
    Kondo, Mayuko
    Goto, Eriko
    Sato, Takahisa
    Kondo, Yuji
    Akamatsu, Masatoshi
    Sato, Shinpei
    Yoshida, Hideo
    Koike, Yukihiro
    Obi, Shuntaro
    JOURNAL OF VIRAL HEPATITIS, 2021, 28 (11) : 1597 - 1603
  • [7] Risk of Hepatocellular Cancer Recurrence in Hepatitis C Virus plus Patients Treated with Direct-Acting Antiviral Agents
    Zou, Winnie Y.
    Choi, Kati
    Kramer, Jennifer R.
    Yu, Xian
    Cao, Yumei
    El-Serag, Hashem B.
    Kanwal, Fasiha
    DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (11) : 3328 - 3336
  • [8] Liver transplantation for hepatitis C virus in the era of direct-acting antiviral agents
    Audrey, Coilly
    Raffaele, Bruno
    CURRENT OPINION IN HIV AND AIDS, 2015, 10 (05) : 361 - 368
  • [9] Assessing the Safety of Direct-Acting Antiviral Agents for Hepatitis C
    McGlynn, Elizabeth A.
    Adams, John L.
    Kramer, Jason
    Sahota, Amandeep K.
    Silverberg, Michael J.
    Shenkman, Elizabeth
    Nelson, David R.
    JAMA NETWORK OPEN, 2019, 2 (06) : e194765
  • [10] Impact of direct-acting antiviral agents on liver function in patients with chronic hepatitis C virus infection
    Johnson, Philip J.
    Berhane, Sarah
    Walker, Alex J.
    Gordon, Fiona H.
    Ryder, Steven D.
    McPherson, Stuart
    Sreedharan, Aravamuthan
    Ustianowski, Andrew A.
    Agarwal, Kosh
    Mutimer, David
    Kumada, Takeshi
    Toyoda, Hidenori
    Irving, William L.
    JOURNAL OF VIRAL HEPATITIS, 2021, 28 (01) : 168 - 176
12345